SGL5213

Modify Date: 2024-01-18 20:45:25

SGL5213 structure	Common Name	SGL5213
	CAS Number	1240305-17-2	Molecular Weight	669.85
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₇H₅₅N₃O₈	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of SGL5213

SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1].

Name	SGL5213

Description	SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> SGLT
Target	IC50: 29nM/20 nM (hSGLT1/ hSGLT2)[1].
References	[1]. Kuroda S, et al. Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment. Bioorg Med Chem. 2019 Jan 15;27(2):394-409.

Molecular Formula	C₃₇H₅₅N₃O₈
Molecular Weight	669.85

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

SGL5213

Use of SGL5213

Names

SGL5213 Biological Activity

Chemical & Physical Properties